We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Imperial College Acquires Gel Scanning System

By HospiMedica staff writers
Posted on 28 Mar 2007
The Institute of Biomedical Engineering at Imperial College (London UK) has announced the acquisition of a Dyversity two-dimensional gel imaging system from Syngene (Cambridge, UK). More...


The Dyversity system, which has been fitted with precision made filters for its UV and visible lighting modules, will be used by up to 200 scientists a year in the Institute of Biomedical Engineering to record images of protein and DNA gels, as well as of blot assays stained with a range of visible, fluorescent, or chemiluminescent dyes. These activities will augment the multiplex imaging of 2-dimensional protein gels.

Syngene, a manufacturer of image analysis systems, is pleased to announce that one of the UK's universities, Imperial College London, has chosen Dyversity, its 2D gel imaging system, to assist in identifying the complex proteins associated with human diseases. The installation provides Syngene with another high-profile customer in the 2D gel market.

Dr Judith Nagy, a researcher at the Institute of Biomedical Engineering, explained, "When the Institute opened last year, we wanted to make sure that our core facilities would support all scientists in the institute and their multi-disciplinary research. This meant that we needed an image acquisition system that could be used in a wide range of research projects to perform the most demanding two-dimensional gel imaging, as well as the simplest gel documentation. Having evaluated four systems from major suppliers, we chose Dyversity because its functionality is equivalent to two imaging systems and a laser scanner, but in one unit. We are delighted to be the first site in the UK to have a Dyversity system.”

Laura Sullivan, divisional manager of Syngene said, "Imperial College is world-renowned for scientific excellence and cutting edge applied medical research. It is a great compliment to know such astute scientists have chosen a Dyversity system and that it will be used as part of so many important proteomics research programs.




Related Links:
Imperial College
Syngene

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
OR Table Accessory
Angular Accessory Rail
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.